Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16th, 2018
Tag: CAR T
Applied DNA Sciences is now BNB Plus Corporation, and our strategy is evolving with a new strategic focus on digital asset treasury management of BNB.
Our new ticker symbol is ‘BNBX’. Learn more here.